Allergic bronchopulmonary aspergillosis

MONDO:0015243

Allergic bronchopulmonary aspergillosis (ABPA) is a rare immunologic pulmonary disorder caused by hypersensitivity to Aspergillus fumigatus, clinically manifesting with poorly controlled asthma and recurrent pulmonary infiltrates.

Also known as: ABPA, Hinson-Pepys disease, allergic aspergillosis, allergic bronchopulmonary aspergillosis, familial, allergic bronchopulmonary mycosis, aspergillosis, allergic bronchopulmonary

24 clinical trials for this condition and its sub-types, 15 tagged with Allergic bronchopulmonary aspergillosis itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Allergic respiratory disease (220) ↑ Aspergillosis (56)

Sub-types of Allergic bronchopulmonary aspergillosis

Malt worker's lung 0 trials

Including sub-types (24) Tagged with Allergic bronchopulmonary aspergillosis (15)

Trials to join now! 15 Not yet recruiting 4 Not yet finished but already full! 1 Completed 4

New allergy shot for teens shows early promise

Symptom relief Ongoing

This study tests a new injection called LP-003 in 6 teenagers aged 12 to 18 who have allergies like hay fever, asthma, or eczema. The main goal is to check if the drug is safe and how the body processes it. This is an early-stage trial, so it focuses on safety and drug levels rat…

Phase 1/2 • Sponsor: Longbio Pharma • Aim: Symptom relief

Last updated Jun 27, 2026 09:06 UTC

Allergic bronchopulmonary aspergillosis

Where it sits in the disease tree

New allergy shot for teens shows early promise